Mesoblastic nephroma
|
Mesoblastic nephroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesoblastic nephroma On the Web |
|
American Roentgen Ray Society Images of Mesoblastic nephroma |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mesoblastic nephroma
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Differential diagnosis
A common differential diagnosis includes the following tumors:
- Mesoblastic nephroma (congenital): from birth to 1 year
- Rhabdoid tumor: from 1 to 2 years of age
- Clear cell sarcoma of the kidney: from 2 to 3 years of age.
- Wilm's tumor: over 3 years of age.
The age breakdown is far from exact, but provides a useful age range and approximate order. Wilm's is most common, accounting for 80-85% of all pediatric kidney tumors. Congenital mesoblastic nephroma accounts for about 10-15%; rhabdoid and CCSK split the remained 5-10%.